Abdul Mannan: The Clinical Pattern That Should Make You Think of VEXAS
Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, shared a post on LinkedIn:
“VEXAS Series – 3 LinkedIn Posts
POST 1 of 3 – VEXAS: The Big Picture
An older man. Fever. Ear chondritis. Macrocytic anaemia. Cytopenia.
Rheumatology refers him to haematology.
Haematology refers him back.
Everyone is partly right. No one has the full answer.
Until you look at his bone marrow.
That’s VEXAS. And it’s sitting in your clinic right now.
VEXAS stands for:
- Vacuoles
- E1 enzyme
- X-linked
- Autoinflammatory
- Somatic
It’s caused by a somatic mutation in the UBA1 gene – the gene that runs the ubiquitin system, the cell’s own protein clean-up mechanism.
When UBA1 fails, cells accumulate stress.
Inflammation ignites.
And the bone marrow starts showing visible damage.
Here’s what to look for clinically:
- Fever and recurrent systemic inflammation
- Chondritis — ears and nose
- Skin lesions
- Eye involvement
- Lung disease
- Macrocytic anaemia with low WBC and/or platelets
And on the bone marrow:
- Vacuoles in early neutrophil precursors
- Vacuoles in early erythroid precursors
One thing every haematologist must know: vacuoles are suggestive, not diagnostic.
MDS, copper deficiency, alcohol excess, malnutrition, and active inflammation can all produce the same picture.
The clinical signal is this: older adult plus inflammation plus cytopenia plus macrocytosis plus vacuolated marrow precursors.
Confirm with UBA1 testing.
This is Part 1 of my 3-part VEXAS series.
Tomorrow: how to use marrow morphology as a practical triage tool.
Have you diagnosed VEXAS in your centre? I’d love to hear your experience.”
Other posts from Abdul Mannan on Hemostasis Today.
-
Sep 22, 2026, 07:11Platelet Dependent Protection Against Bacterial Pneumonia – JTH
-
Sep 22, 2026, 07:10Sumita Pandey: Apheresis Beyond Automation
-
Sep 22, 2026, 07:04Wafik El-Deiry: Type 1 interferon Alters Clonal Competition in Human Blood Development
-
Sep 22, 2026, 06:53Tania L.: Women in Hematology Take the Stage in Austin
-
Sep 22, 2026, 06:35Mahmoud Hanafy: Hayat National Hospitals Achieves AABB Accreditation
-
Sep 22, 2026, 06:01Nikola Pantic: New ASH ITP Guidelines Transform First-Line Treatment
-
Sep 22, 2026, 04:43Michael Cahillane: Highlights From BBTS2026 in Glasgow
-
Sep 22, 2026, 04:15Wolfgang Miesbach: First AAV Gene Therapy Data in Adolescents With Haemophilia B
-
Sep 22, 2026, 04:03Emmanuel J Favaloro: 100 Years of VWD – A Special Virtual Issue